Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/1996
06/27/1996WO1996019451A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996WO1996019440A1 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
06/27/1996WO1996019233A2 Irrigation solution and method for inhibition of pain, inflammation and spasm
06/27/1996CA2341921A1 Amide compounds intermediates
06/27/1996CA2208530A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996CA2208316A1 Oxazole derivatives and use thereof
06/27/1996CA2206978A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
06/27/1996CA2206059A1 Improved cyclic crf antagonists
06/27/1996CA2183645A1 Heterocyclic aromatic oxazole compounds and use thereof
06/26/1996EP0718312A2 Crosslinked acidic polysaccharides and their uses
06/26/1996EP0718287A2 Piperazine derivatives, medicaments containing them, their use, and processes for their preparation
06/26/1996EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies
06/26/1996EP0717624A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
06/26/1996EP0717616A1 Process for conditioning substances
06/26/1996CN1125449A Sialyl Lex analogues as inhibitors of cellular adhesion
06/26/1996CN1125445A Novel chemical compounds having PDE-IV inhibition activity
06/26/1996CN1125442A Imidazole lipoxygenase inhibitors
06/26/1996CN1125436A Vitamin D amide derivatives
06/26/1996CN1125398A Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
06/26/1996CN1125221A 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect
06/25/1996US5530157 Anti-inflammatory benzoic acid derivatives
06/25/1996US5530128 Enzyme inhibitor as antitumor agent
06/25/1996US5530101 Humanized immunoglobulins
06/25/1996US5530009 Treating asthma
06/25/1996US5530003 Pharmaceutical compositions for curing rheumatism
06/25/1996US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE
06/25/1996US5529792 Homogenizing chicken embryo or adult bovine brain tissue, centrifuging, applying to cation exchanger, separating active fractions by gel filtration chromatography, purifying by reverse phase liquid chromatography
06/24/1996CA2165922A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
06/23/1996CA2165890A1 Crosslinked acidic polysaccharides and their uses
06/20/1996WO1996018725A1 Human tissue inhibitor of metalloproteinase-4
06/20/1996WO1996018649A1 Improved cyclic crf agonists
06/20/1996WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
06/20/1996WO1996018643A1 Tachykinin antagonists
06/20/1996WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
06/20/1996WO1996018403A1 Combined use of diclofenac and tribenoside to treat osteoarthritis
06/20/1996WO1996018399A1 Aryl thioxanthines
06/20/1996WO1996018393A1 Novel compounds
06/20/1996WO1996018382A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
06/20/1996WO1996018381A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
06/20/1996WO1996018380A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations
06/20/1996WO1996018379A1 Cosmetic and dermatological preparations with flavonoids
06/20/1996WO1996018372A2 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
06/20/1996CA2207911A1 Combined use of diclofenac and tribenoside to treat osteoarthritis
06/20/1996CA2207576A1 Improved cyclic crf agonists
06/20/1996CA2204130A1 Tachykinin antagonists
06/20/1996CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling
06/19/1996EP0717040A1 Thiazine or thiazepine derivatives which inhibit NOS
06/19/1996EP0717034A1 Vitamin D compounds and method of preparing these compounds
06/19/1996EP0717027A1 Diarylheptanoide derivative and pharmaceutical composition comprising the same
06/19/1996EP0716847A1 Cosmetic or dermatologic compositions containing cinnamic acid derivatives and a flavonoid
06/19/1996EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists
06/19/1996EP0716652A1 Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
06/19/1996EP0716611A1 Method to reduce myocardial injury during acute myocardial infarction
06/19/1996EP0716600A1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
06/19/1996CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists
06/19/1996CN1124925A Lotion
06/18/1996US5527890 Derivatives of triterpenoid acids and uses thereof
06/18/1996US5527827 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
06/15/1996CA2164916A1 Vitamin d compounds and method of preparing these compounds
06/15/1996CA2164163A1 Diarylheptanoide derivative and pharmaceutical composition comprising the same
06/15/1996CA2155627A1 Thiazine- or thiazepine-derivatives
06/13/1996WO1996017935A2 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
06/13/1996WO1996017874A1 Monoclonal antibody fragments having immunosuppressant activity
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins
06/13/1996WO1996017845A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996WO1996017838A1 Malonic acid based matrix metalloproteinase inhibitors
06/13/1996WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation
06/13/1996CA2207036A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
06/13/1996CA2206965A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996CA2206665A1 Malonic acid based matrix metalloproteinase inhibitors
06/13/1996CA2206471A1 Monoclonal antibody fragments having immunosuppressant activity
06/12/1996EP0715619A1 Inhibitors of tnf-alpha secretion
06/12/1996EP0715519A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
06/12/1996EP0503044B1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof
06/12/1996CN1124486A Heterocycle-containing amidine derivatives, their preparation and use
06/12/1996CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products
06/12/1996CN1124250A 17-deoxycorticosteroid-21-|O¨-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
06/12/1996CN1032019C Process for recombinant biocides using organisms
06/11/1996US5525629 Inhibition of cytokine production
06/11/1996US5525624 A 3-benzoyl,4-oxyphenylbenzothiophene compound
06/11/1996US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine
06/11/1996US5525608 17b-aryl-4-aza-steroid derivatives useful as 5-alpha-reductase inhibitors
06/11/1996US5525602 Method of using 4-amino 6-substituted mycophenolic acid and derivatives
06/11/1996US5525590 Immunosuppressants, antiinflammatory and antiparasitic
06/11/1996US5525338 Detection and therapy of lesions with biotin/avidin conjugates
06/11/1996CA1338381C Minactivin - (plasminogen activator inhibitor-2)
06/06/1996WO1996016990A1 Humanized antibodies to cd38
06/06/1996WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases
06/06/1996WO1996016970A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016967A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/06/1996WO1996016955A1 Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline
06/06/1996WO1996016952A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p
06/06/1996WO1996016934A1 Substituted biphenyl compounds for the treatment of inflammation
06/06/1996WO1996016931A1 Metalloproteinase inhibitors
06/06/1996WO1996016654A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
06/06/1996CA2206257A1 Substituted biphenyl compounds for the treatment of inflammation
06/06/1996CA2205972A1 Metalloproteinase inhibitors
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 1272